Cost-effective culture of human induced pluripotent stem cells using UV/ozone-modified culture plastics with reduction of cell-adhesive matrix coating-Reference-Cited by-同舟云学术

Cost-effective culture of human induced pluripotent stem cells using UV/ozone-modified culture plastics with reduction of cell-adhesive matrix coating

Published:2020-06 Issue: Volume:111 Page:110788
ISSN:0928-4931
Container-title:Materials Science and Engineering: C
language:en
Short-container-title:Materials Science and Engineering: C

Author:

Kasai Kohei,Tohyama Shugo,Suzuki Hayato,Tanosaki Sho,Fukuda Keiichi,Fujita Jun,Miyata Shogo^ORCID

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Biomaterials,Bioengineering,Mechanics of Materials

Reference34 articles.

1. Establishment in culture of pluripotential cells from mouse embryos;Evans;Nature,1981

2. Feeder-free growth of undifferentiated human embryonic stem cells;Xu;Nat. Biotechnol.,2001

3. Adaptation of human pluripotent stem cells to feeder-free conditions in chemically defined medium with enzymatic single-cell passaging;Stover;Methods Mol. Biol.,2011

4. Feeder- and serum-free establishment and expansion of human induced pluripotent stem cells;Totonchi;Int. J. Dev. Biol.,2010

5. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511;Rodin;Nat. Biotechnol.,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cells in orthopaedics and sports injuries: A comprehensive review and future research directions;Journal of Orthopaedic Reports;2024-12

2. Long non-coding RNA Snhg16 Lessens Ozone Curative Effect on Chronic Constriction Injury mice via microRNA-719/SCN1A axis;Molecular Biotechnology;2023-08-26

3. A chemically-defined plastic scaffold for the xeno-free production of human pluripotent stem cells;Scientific Reports;2022-02-15

4. Clinical Application of iPSC-Derived Cardiomyocytes in Patients with Advanced Heart Failure;Advanced Technologies in Cardiovascular Bioengineering;2022

5. Development of Cardiac Regenerative Medicine Using Human iPS Cell-derived Cardiomyocytes;KEIJO J MED;2020